Virax Biolabs Group News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

23.10.24	Virax Biolabs Signs Distribution Agreement With Europa Biosite To Sell ImmuneSelect; Stock Up (RTTNews)
28.08.24	Why Virax Biolabs Is Rising In Pre-market? (RTTNews)
19.04.23	Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits (PR Newswire)
10.03.23	Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire)
08.03.23	Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire)
07.02.23	Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) (PR Newswire)
06.02.23	Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference (PR Newswire)
02.02.23	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire)
04.01.23	Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit (PR Newswire)
06.12.22	COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States (PR Newswire)
15.11.22	Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales (PR Newswire)
08.11.22	Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement (PR Newswire)
04.11.22	Virax Biolabs Group Limited Announces $3.8 Million Private Placement (PR Newswire)
03.11.22	Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit (PR Newswire)
26.10.22	Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study (PR Newswire)
16.08.22	Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.32	2.01 %	K V
Alcon	79.46	1.90 %	K V
Sonova Hldg	308.90	1.55 %	K V
ABB	51.64	1.29 %	K V
Lonza Grp	570.20	1.24 %	K V
Kuehne+Nagel Int	206.80	0.05 %	K V
Givaudan	3’960.00	-0.08 %	K V
Sika	227.00	-0.09 %	K V
Geberit	505.40	-0.20 %	K V
UBS Group	31.54	-0.66 %	K V